REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers

被引:25
作者
Rijnbeek, B [1 ]
de Visser, SJ [1 ]
Franson, KL [1 ]
Cohen, AF [1 ]
van Gerven, JMA [1 ]
机构
[1] Ctr Human Drug Res, NL-2333 CL Leiden, Netherlands
关键词
antidepressive agents; CNS active drugs; healthy human; REM sleep;
D O I
10.1177/0269881103017002008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The potential use of rapid eye movement (REM) sleep effects as a biomarker for the therapeutic effects of antidepressants in healthy volunteers is reviewed. A literature search was performed-to select studies investigating the effects-of antidepressants on REM sleep. To assess the specificity of REM sleep effects as a biomarker, the effects: of other central nervous system drugs I on REM sleep were also investigated. A significant REM, sleep reduction was shown for 16 of 21 investigated antidepressants after single-dose (mean reduction 34.1%) and for 11/13 drugs after multiple-dose administration (mean reduction 29.2%),. The median increase in - REM latency was approximately 60% after single- or multiple-dose administration. REM sleep effects were linearly normalized to therapeutic doses, by dividing the REM sleep effect by the investigated dose and multiplying by the therapeutic dose. Normalized REM sleep effects were highly variable (range -27.0% to -81.8% for REM sleep; range -17.0% to 266.3% for REM latency) and demonstrated no relationship with relevant, pharmacological properties of the investigated drugs. No quantifiable dose-response relationship c be constructed'a s ngle and multiple dose administration. REM sleep- effectswere not specific for antidepressants. Benzodiazepines, for example, caused an average dose normalized REM sleep reduction of 8.7% and a median 8.6% increase of REM latency. This review demonstrates that although REM sleep effects occur with most of the antidepressants,- it is by itself of limited value as a. biomarker for antidepressant action. The specificity for antidepressants is limited, and it does not show a quantitative dose-response relationship to antidepressant agents. This is at least partly due to the complex relationships between drug pharmacokinetics and. the variable time course of REM and other sleep stages throughout the night. Models that take these complex,relationships into accounts may provide more, comprehensive and quantifiable results.
引用
收藏
页码:196 / 203
页数:8
相关论文
共 70 条
[1]   A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients [J].
Armitage, R ;
Yonkers, K ;
Cole, D ;
Rush, AJ .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (03) :161-168
[2]   THE EFFECTS OF NEFAZODONE ON SLEEP ARCHITECTURE IN DEPRESSION [J].
ARMITAGE, R ;
RUSH, AJ ;
TRIVEDI, M ;
CAIN, J ;
ROFFWARG, HP .
NEUROPSYCHOPHARMACOLOGY, 1994, 10 (02) :123-127
[3]  
Blois R, 1990, Acta Psychiatr Scand Suppl, V360, P73
[4]   ULTRADIAN DYNAMICS OF SLEEP AFTER A SINGLE DOSE OF BENZODIAZEPINE HYPNOTICS [J].
BORBELY, AA ;
ACHERMANN, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 195 (01) :11-18
[5]  
BORBELY AA, 1985, HUM NEUROBIOL, V4, P189
[6]   EFFECT OF ZOLPIDEM ON SLEEP AND SLEEP EEG SPECTRA IN HEALTHY-YOUNG MEN [J].
BRUNNER, DP ;
DIJK, DJ ;
MUNCH, M ;
BORBELY, AA .
PSYCHOPHARMACOLOGY, 1991, 104 (01) :1-5
[7]   Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications [J].
Feinberg, I ;
Maloney, T ;
Campbell, IG .
JOURNAL OF PSYCHIATRIC RESEARCH, 2000, 34 (06) :423-438
[8]  
Fernandez-Guardiola A, 1978, Bol Estud Med Biol, V30, P105
[9]   TRIMIPRAMINE - ACUTE AND LASTING EFFECTS ON SLEEP IN HEALTHY AND MAJOR DEPRESSIVE SUBJECTS [J].
FEUILLADE, P ;
PRINGUEY, D ;
BELUGOU, JL ;
ROBERT, P ;
DARCOURT, G .
JOURNAL OF AFFECTIVE DISORDERS, 1992, 24 (03) :135-146
[10]   The effects of REM sleep-inhibiting drugs in neonatal rats: evidence for a distinction between neonatal active sleep and REM sleep [J].
Frank, MG ;
Page, J ;
Heller, HC .
BRAIN RESEARCH, 1997, 778 (01) :64-72